US20250230125A1
University of Texas System
The present invention relates to novel 5HT receptor modulators, such as compounds of the general Formula (I) and general Formula (II):or a pharmaceutically acceptable salt thereof. Methods of using the compounds include, for example, modulation of 5-hydroxytryptamine (5-HT) receptor subtypes, …